Paôline reported that in SSc patients, CCL2 can be produced at high levels by DC-SIGN- positive alternatively activated macrophages, a type of macrophage related to the degree of skin fibrosis in SSc patients, indicating that CCL2 is involved in the vicious cycle of skin fibrosis in SSc patients26. This evidence concerns the gene CD209 and systemic sclerosis.